HK:6667 Stock Latest News
Company AnnouncementsMega Genomics Seeks Major Increase to 2026 Cap Under Meinian Deal3d ago6667
Company AnnouncementsMega Genomics Accelerates Revenue Growth as Product Mix Shift Pressures Profit2M ago6667
Company AnnouncementsMega Genomics Sets Board Meeting to Approve Interim Results and Consider Dividend3M ago6667
Company AnnouncementsMega Genomics Revamps Hong Kong Governance Roles and Relocates Principal Office3M ago6667
Company AnnouncementsMega Genomics Sets Final Dividend and Payment Timetable for FY20255M ago6667
Company AnnouncementsMega Genomics Wins Unanimous Shareholder Backing at 2026 AGM5M ago6667Company AnnouncementsMega Genomics Sets Final Dividend and Updates FX Rate for 2025 Payout5M ago6667
- Company AnnouncementsMega Genomics Sets Final 2025 Dividend and Confirms Payment Timetable6M ago6667
Company AnnouncementsMega Genomics sets 2026 AGM to approve dividend, director slate and share buyback mandate6M ago6667
Company AnnouncementsMega Genomics Reschedules AGM and Adjusts Share Register Closure6M ago6667
Company AnnouncementsMega Genomics Delivers Strong Revenue Growth but Faces Profit Drag from One-Off Costs7M ago6667
Company AnnouncementsMega Genomics Declares Proposed Final Dividend for 2025, Details to Follow7M ago6667Company AnnouncementsMega Genomics Flags Profit Drop for 2025 Despite Strong Revenue Growth7M ago6667
Company AnnouncementsMega Genomics Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend7M ago6667
Company AnnouncementsMega Genomics Clears Audit Concerns and Prepares to Resume Trading in Hong Kong8M ago6667
Company AnnouncementsMega Genomics Posts Lower First-Half 2025 Revenue but Improves Margins Amid Strategy Shift9M ago6667- Company AnnouncementsMega Genomics Boosts Profit on Consumer Genetic Testing Growth Despite Cancer Screening Slump9M ago6667
Company AnnouncementsMega Genomics Sets February Board Meeting to Approve 2025 Interim Results9M ago6667
Company AnnouncementsMega Genomics Sets January 2026 Board Meeting to Approve 2024 Final Results and Dividend Plan9M ago6667Company AnnouncementsMega Genomics Completes Internal Control Overhaul to Meet HKEX Resumption Demands9M ago6667
Company AnnouncementsMega Genomics Advances Governance Reforms as Operations Remain Stable During Trading Suspension10M ago6667